{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "firstTradeDateMilliseconds": 1585033200000, "priceHint": 4, "epsTrailingTwelveMonths": -3913.1, "sharesOutstanding": 18925900, "bookValue": 2.919, "fiftyDayAverage": 0.797198, "fiftyDayAverageChange": -0.595198, "fiftyDayAverageChangePercent": -0.7466125, "twoHundredDayAverage": 5.5858197, "twoHundredDayAverageChange": -5.3838196, "twoHundredDayAverageChangePercent": -0.96383697, "marketCap": 3823032, "priceToBook": 0.06920178, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Midatech Pharma plc", "nameChangeDate": "2023-05-11", "tradeable": false, "cryptoTradeable": false, "regularMarketChangePercent": -12.173912, "regularMarketPrice": 0.202, "marketState": "REGULAR", "exchange": "FRA", "shortName": "BIODEXA PHARMA SP.ADR/5", "longName": "Biodexa Pharmaceuticals Plc", "messageBoardId": "finmb_278298574", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChange": -0.027999997, "regularMarketTime": 1683871215, "regularMarketDayHigh": 0.202, "regularMarketDayRange": "0.202 - 0.202", "regularMarketDayLow": 0.202, "regularMarketVolume": 4400, "regularMarketPreviousClose": 0.23, "bid": 0.207, "ask": 0.235, "fullExchangeName": "Frankfurt", "financialCurrency": "GBP", "regularMarketOpen": 0.202, "averageDailyVolume3Month": 896, "averageDailyVolume10Day": 2220, "fiftyTwoWeekLowChange": 0.0335, "fiftyTwoWeekLowChangePercent": 0.19881305, "fiftyTwoWeekRange": "0.1685 - 15.5", "fiftyTwoWeekHighChange": -15.298, "fiftyTwoWeekHighChangePercent": -0.98696774, "fiftyTwoWeekLow": 0.1685, "fiftyTwoWeekHigh": 15.5, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "5MP1.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1 Caspian Point", "address2": "Caspian Way", "city": "Cardiff", "zip": "CF10 4DQ", "country": "United Kingdom", "phone": "44 29 2048 0180", "website": "https://www.biodexapharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Biodexa Pharmaceuticals Plc, a drug delivery technology company, focuses on the bio-delivery and biodistribution of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was formerly known as Midatech Pharma plc and changed its name to Biodexa Pharmaceuticals Plc in March 2023. Biodexa Pharmaceuticals Plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.", "fullTimeEmployees": 27, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stephen A. Stamp", "age": 60, "title": "CEO, CFO, Company Sec. & Director", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": {"raw": 300344, "fmt": "300.34k", "longFmt": "300,344"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Dmitry  Zamoryakhin M.D.", "age": 42, "title": "Chief Scientific Officer", "yearBorn": 1980, "fiscalYear": 2022, "totalPay": {"raw": 298802, "fmt": "298.8k", "longFmt": "298,802"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Daniel  Palmer MBA, Ph.D.", "title": "VP of Technology", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Vincent  Holmes", "title": "VP & Head of Clinical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Fiona  Sharp", "title": "Group Financial Controller", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}